Skip to main content
RemeGen Co., Ltd. logo

RemeGen Co., Ltd. — Investor Relations & Filings

Ticker · 9995 ISIN · CNE1000048G6 LEI · 300300M9HCX4TFAD4I10 HKEX Manufacturing
Open in API
Filings indexed 1,625 across all filing types
Latest filing 2017-11-10 Regulatory Filings
Country CN China
Listing HKEX 9995

About RemeGen Co., Ltd.

http://www.remegen.com

RemeGen Co., Ltd. is a biopharmaceutical company dedicated to the discovery, development, production, and commercialization of innovative biological drugs. The company focuses on creating first-in-class and best-in-class therapeutics to address significant unmet clinical needs, particularly in the critical therapeutic areas of autoimmune diseases, oncology, and ophthalmology. RemeGen utilizes proprietary technology platforms capable of discovering, screening, and developing new molecules and efficiently optimizing production processes. Its pipeline includes a series of innovative biologics, such as Telitacicept, and features 8 clinical pipelines, over 40 clinical trials, and more than 600 patent applications, demonstrating a strong commitment to R&D and innovation in biopharmaceuticals.

Recent filings

Filing Released Lang Actions
TRADING HALT
Regulatory Filings Classification · 95% confidence The document is a short announcement from Overseas Chinese Town (Asia) Holdings Limited regarding a trading halt on its shares and debt securities pending the release of an announcement related to a very substantial disposal. The text is brief (1473 characters) and does not contain any financial data, detailed report content, or analysis. It is clearly an announcement about a trading halt and an upcoming announcement, not a full report or detailed filing. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2017-11-10 English
EXCHANGE NOTICE - TRADING HALT
Regulatory Filings Classification · 95% confidence The document is a short notice from an exchange regarding a trading halt for a specific company's shares and debt securities. It does not fit into specific categories like earnings, dividends, or annual reports. As it is a general regulatory announcement regarding market activity, it falls under the RNS category.
2017-11-10 English
Monthly Return of Equity Issuer on Movement in Securities for the month ended 31 October 2017
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31/10/2017, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorized share capital, issued share capital, share options, warrants, convertibles, and other share-related transactions. The content focuses on share capital changes and movements rather than financial performance, earnings, or management commentary. It is a regulatory filing reporting monthly share capital movements for a listed issuer. The document is not an annual or interim report, earnings release, or management discussion. It is a regulatory compliance report specific to share capital movements, which fits best under the category of Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2017-11-01 English
Notice of listing of US.$800,000,000 senior guaranteed perpetual capital securities issued by Overseas Chinese Town (Asia) Holdings Limited
Capital/Financing Update Classification · 95% confidence The document is an announcement from Overseas Chinese Town (Asia) Holdings Limited regarding the listing of US$800,000,000 senior guaranteed perpetual capital securities on the Hong Kong Stock Exchange. It includes details about the securities, the listing application, the expected effective date, and the board composition. The text explicitly states it is a "NOTICE OF LISTING" and provides information about the securities offering and listing process. The document is relatively short (3443 characters) and serves as an official notice rather than a detailed financial report or prospectus. It does not contain financial statements, management discussion, or detailed financial data. Therefore, it is best classified as a Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes such as new securities issuance and listing announcements.
2017-10-11 English
Monthly Return of Equity Issuer on Movement in Securities for the month ended 30 September 2017
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 30/09/2017, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other share capital changes. The content is focused on share capital changes and movements rather than financial performance, earnings, or management commentary. It is a regulatory filing reporting share capital movements for a specific month, typical of a regulatory compliance report rather than a financial report or announcement. The document length is substantial (over 14,000 characters), indicating it is a full report rather than a brief announcement. Given the nature of the content and the regulatory context, the most appropriate classification is Regulatory Filings (RNS), as it does not fit into other more specific categories like Share Issue/Capital Change (SHA) because it is a monthly return report rather than a single announcement of a capital change event.
2017-10-03 English
CONTINUING CONNECTED TRANSACTIONS RENEWAL OF TENANCY AGREEMENT
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the renewal of a tenancy agreement between the company and a connected party. It details the terms of the tenancy, historical transaction amounts, annual caps, reasons for the agreement, and listing rules implications. The document is lengthy (over 12,000 characters) and contains detailed transactional information but does not present financial statements or results. It is clearly an announcement of a continuing connected transaction under the Listing Rules, not a financial report, earnings release, or management discussion. It is not a regulatory certification or a report publication announcement. The content fits the category of a regulatory announcement about connected transactions, which is best classified under Regulatory Filings (RNS) as it does not fit other more specific categories like Capital/Financing Update or Board/Management Information. Therefore, the appropriate classification is Regulatory Filings (RNS) with high confidence.
2017-09-29 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.